1. High Cure Rates of the Short-Term GITIL Chemotherapy Programme for Adult Patients with Burkitt Lymphoma by Jacopo Mariotti, Anna Guidetti, Michele Magni, Paola Matteucci, Liliana Devizzi, Andrés J.M. Ferreri, Paolo Corradini, Anna Dodero, Amalia De Renzo, Alessandro Massimo Gianni, and Massimo Di Nicola Blood Volume 124(21):1734-1734 December 6, 2014 ©2014 by American Society of Hematology

2. 5-year OS of patients with Burkitt lymphoma treated with a short-intensive chemotherapy regimen. Jacopo Mariotti et al. Blood 2014;124:1734 ©2014 by American Society of Hematology

3. 5-year Cumulative Incidence of relapse (with 95% confidential interval) of patients with Burkitt lymphoma treated with a short-intensive chemotherapy regimen. Jacopo Mariotti et al. Blood 2014;124:1734 ©2014 by American Society of Hematology